0001062993-23-009156.txt : 20230413 0001062993-23-009156.hdr.sgml : 20230413 20230413180948 ACCESSION NUMBER: 0001062993-23-009156 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20230413 DATE AS OF CHANGE: 20230413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAVmed Inc. CENTRAL INDEX KEY: 0001624326 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40901 FILM NUMBER: 23819349 BUSINESS ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (212) 949-4319 MAIL ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER NAME: FORMER CONFORMED NAME: PAXmed Inc. DATE OF NAME CHANGE: 20141105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucid Diagnostics Inc. CENTRAL INDEX KEY: 0001799011 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 825488042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212 949 4319 MAIL ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4/A 2022-11-30 2022-12-02 0001799011 Lucid Diagnostics Inc. LUCD 0001624326 PAVmed Inc. 360 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10017 0 0 1 0 0 Common stock 2022-11-30 4 J 0 1145086 1.8383 A 29072276 D Common Stock 2022-11-30 4 J 0 197656 2.7826 A 29269932 D Common Stock 2022-11-30 4 J 0 221952 2.4780 A 29491884 D Common Stock 2022-11-30 4 J 0 331210 1.6606 A 29823094 D Common Stock 2022-11-30 4 J 0 1479326 1.8383 A 31302420 D Issuance of common stock by the Issuer to the Reporting Person in satisfaction of a commercial agreement. This Form 4 Amendment is being filed for the sole purpose of correcting the Amount of Securities Beneficially Owned Following Reported Transactions in Column 5 of Table I. In every other regard, this Form 4/A is identical to the Form 4 filed on December 2, 2022. /s/ Dennis M. McGrath, as Secretary of the Reporting Person 2023-04-13